GEN Exclusives

More »

GEN News Highlights

More »
Dec 16, 2011

Standard of Care, Overseas Opportunities Top Strategies Firms Use to Overcome MDX Reimbursement Issues

  • Exactly half of respondents to a GEN poll say their companies are working to gain provider acceptance and reimbursement for personalized medicine by pursuing standard-of-care status for their molecular diagnostics. Another third (33.3%) are concentrating their efforts on developing diagnostics for markets outside the U.S., while 16.7% said they are forming partnerships with the pharmaceutical industry. Steven Burrill, CEO of Burrill & Company, has likened gaining acceptance for personalized medicine diagnostics to hand-to-hand combat: “Investors were naïve at how substantial and perverse the resistance to adoption is.”


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should the CDC Director Resign?

Do you think the CDC chief should resign?